Charity D. Scripture
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 5
- Lung Cancer Research Studies 4
- CAR-T cell therapy research 1
-
- Pharmacogenetics and Drug Metabolism 6
- Co-authors
- William Douglas Figg (12 shared papers)Alex Sparreboom (8 shared papers)John A. Pieper (1 shared paper)Neil P. Desai (2 shared papers)Michael Hawkins (2 shared papers)Tapas De (1 shared paper)Vuong N. Trieu (1 shared paper)Andrew Jihoon Yang (1 shared paper)
- Journals
- Clinical Cancer Research (3 papers)Annals of Oncology (3 papers)Current Neuropharmacology (1 paper)Lung Cancer (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United StatesJapanHungary
In The Last Decade
Charity D. Scripture
18 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 95
- Biomaterials 409
- Pharmacology 246
- Geriatrics and Gerontology 75
- Drug Discovery 6
- Oncology 453
Countries citing papers authored by Charity D. Scripture
This map shows the geographic impact of Charity D. Scripture's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charity D. Scripture with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charity D. Scripture more than expected).
Fields of papers citing papers by Charity D. Scripture
This network shows the impact of papers produced by Charity D. Scripture. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charity D. Scripture. The network helps show where Charity D. Scripture may publish in the future.
Co-authors
The 25 scholars most cited alongside Charity D. Scripture, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 442 | |
| 2 | 2006 | 302 | |
| 3 | 2006 | 261 | |
| 4 | 2008 | 203 | |
| 5 | 2008 | 152 | |
| 6 | 2001 | 142 | |
| 7 | 2005 | 107 | |
| 8 | 2006 | 83 | |
| 9 | 2005 | 67 | |
| 10 | 2024 | 32 | |
| 11 | 2019 | 27 | |
| 12 | 2005 | 21 | |
| 13 | 2004 | 17 | |
| 14 | 2005 | 11 | |
| 15 | 2005 | 8 | |
| 16 | 2006 | 7 | |
| 17 | 2017 | 2 | |
| 18 | 2017 | 1 | |
| 19 | 2018 | 0 |
About Charity D. Scripture
Charity D. Scripture is a scholar working on Oncology, Pharmacology, Biomaterials, Pulmonary and Respiratory Medicine and Analytical Chemistry, having authored 19 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Cancer Treatment and Pharmacology (5 papers), Lung Cancer Research Studies (4 papers), Nanoparticle-Based Drug Delivery (2 papers), Prostate Cancer Treatment and Research (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Lung Cancer Treatments and Mutations (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Biomaterials (409 citations), Pharmacology (246 citations), Geriatrics and Gerontology (75 citations), Drug Discovery (6 citations) and Oncology (453 citations). Charity D. Scripture has collaborated with scholars based in United States, Japan and Hungary. Frequent co-authors include William Douglas Figg, Alex Sparreboom, John A. Pieper, Neil P. Desai, Michael Hawkins, Tapas De, Vuong N. Trieu, Andrew Jihoon Yang, Bridget Beals and Jeanny B. Aragon‐Ching. Their work appears in journals such as Clinical Cancer Research, Annals of Oncology, Current Neuropharmacology, Lung Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.